This Week in Virology

TWiV 949: Clinical update with Dr. Daniel Griffin


Listen Later

In his weekly clinical update Dr. Griffin discusses progress toward poliomyelitis eradication in Pakistan, polio by the numbers , influenza and COVID-19 vaccination coverage among health care personnel, phase 1/2a safety and immunogenicity of an adenovirus 26 vector RSV vaccine encoding prefusion F in adults 18–50 years and RSV seropositive children 12–24 months, receipt of first and second doses of JYNNEOS vaccine for prevention of Monkeypox, distinguishing SARS-CoV-2 persistence and reinfection, Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages, association between regular physical activity and the protective effect of vaccination against SARS-CoV-2 in a South African case, COVID-19 outcomes in solid organ transplant recipients who received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab treatment, Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralizing antibodies, and Tocilizumab versus Baricitinib in hospitalized patients with severe COVID-19.

Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode
  • Progress toward Poliomyelitis eradication (CDC)
  • Polio by the numbers (JID)
  • Influenza & COVID-19 vaccination coverage among health care personnel (CDC)
  • Phase 1/2a Safety & Immunogenicity of an adenovirus RSV Vaccine (JID)
  • Receipt of first & second doses of JYNNEOS vaccine  (CDC)
  • Distinguishing SARS-CoV-2 persistence and reinfection (CID)
  • Remdesivir fact sheet for providers (Veklury)
  • Bebtelovimab fact sheet for providers (FDA)
  • Novavax triggers potent neutralization of Omicron sub-lineages (bioRxiV)
  • Association between physical activity & vaccination protective effect (BMJ)
  • PAXLOVID patient eligibility screening checklist (FDA)
  • COVID-19 outcomes in solid organ transplant recipients who received monoclonal antibodies (Transplantation)
  • Omicron BA.2.75.2 exhibits escape from neutralizing antibodies (bioRxiV)
  • Tocilizumab vs. Baricitinib in hospitalized patients with severe COVID-19 (CMI)
  • Dr. Griffin’s treatment guide (pdf)
  • Contribute to Floating Doctors fundraiser at PWB
  • Letters read on TWiV 949
  • Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]

...more
View all episodesView all episodes
Download on the App Store

This Week in VirologyBy Vincent Racaniello

  • 4.7
  • 4.7
  • 4.7
  • 4.7
  • 4.7

4.7

205 ratings


More shows like This Week in Virology

View all
On the Media by WNYC Studios

On the Media

9,203 Listeners

Nature Podcast by Springer Nature Limited

Nature Podcast

767 Listeners

Science Magazine Podcast by Science Magazine

Science Magazine Podcast

823 Listeners

This Week in Virology by Vincent Racaniello

This Week in Virology

2,058 Listeners

This Week in Parasitism by Vincent Racaniello

This Week in Parasitism

456 Listeners

This Week in Microbiology by Vincent Racaniello

This Week in Microbiology

517 Listeners

This Week in Evolution by Vincent Racaniello

This Week in Evolution

168 Listeners

Immune by Vincent Racaniello

Immune

275 Listeners

America Dissected by Incision Media LLC

America Dissected

4,493 Listeners

In the Bubble with Andy Slavitt by Lemonada Media

In the Bubble with Andy Slavitt

3,476 Listeners

The Ezra Klein Show by New York Times Opinion

The Ezra Klein Show

16,210 Listeners

Infectious Disease Puscast by Vincent Racaniello

Infectious Disease Puscast

85 Listeners

Ground Truths by Eric Topol

Ground Truths

48 Listeners

Letters from an American by Heather Cox Richardson

Letters from an American

5,688 Listeners

Why Should I Trust You? by Brinda Adhikari, Tom Johnson, Maggie Bartlett, Dr. Mark Abdelmalek

Why Should I Trust You?

95 Listeners